Understanding a new iron treatment for anemia
Development of Advanced Analytical Methods for the Characterization of Iron Carbohydrate Complex - Ferric Derisomaltose
['FUNDING_U01'] · UNIVERSITY OF MARYLAND BALTIMORE · NIH-10491846
This study is looking at a new iron treatment called Monoferric to better understand how it works, so we can make it safer and more effective for people with iron deficiency anemia.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MARYLAND BALTIMORE (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10491846 on ClinicalTrials.gov |
What this research studies
This research focuses on the characterization of Monoferric, a newly approved intravenous iron treatment for iron deficiency anemia (IDA). The study aims to explore the complex structure of Monoferric, including its iron core and carbohydrate shell, using advanced analytical techniques. By improving our understanding of this drug, the research seeks to enhance its effectiveness and safety for patients requiring iron supplementation. The approach involves a multidisciplinary methodology that combines various sophisticated analytical methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with iron deficiency anemia who may benefit from intravenous iron treatments.
Not a fit: Patients who do not have iron deficiency anemia or those who are not candidates for intravenous iron therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for patients suffering from iron deficiency anemia.
How similar studies have performed: Previous research on intravenous iron treatments has shown promise, indicating that this approach could lead to significant advancements in the management of iron deficiency anemia.
Where this research is happening
BALTIMORE, UNITED STATES
- UNIVERSITY OF MARYLAND BALTIMORE — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MICHEL, SARAH L — UNIVERSITY OF MARYLAND BALTIMORE
- Study coordinator: MICHEL, SARAH L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.